Oxalys Pharmaceuticals

oxalys.ca

Oxalys Pharmaceuticals is focused on developing effective therapies for neurodegenerative disorders, particularly Huntington's and Parkinson's diseases. Founded by scientists from MIT, the company utilizes advanced drug discovery methods to create neuroprotective compounds that target the underlying causes of brain degeneration. Their lead therapeutic, OXD4, shows promise in preclinical tests and aims to halt disease progression. Supported by notable organizations like the Michael J Fox Foundation, Oxalys collaborates with industry experts to bring innovative solutions to market, positioning itself as a leader in the neurodegenerative disease space.